MarketBeat is providing consensus rating for Alamar Biosciences, and Leerink Partners and Bank of America have initiated coverage on the company.

The entities involved

• MarketBeat →

  American personal finance blog

  • MarketBeat reported consensus ratings and target prices for Deep Fission Inc., which received a strong-buy rating from Benchmark.Fri 23:44
  • Several financial firms, including Raymond James Financial and Truist Financial, issued multiple rating and price target updates on November 6, 2026.Fri 22:59
• Leerink partners →

  U.S. investment bank

  • Leerink Partners provided coverage and price targets for Freenome on September 26, 2026.Fri 19:28
  • Leerink Partners started coverage on ANI Pharmaceuticals shares.Fri 05:52
• Bank of America →

  American multinational banking and financial services corporation

  • Multiple major banks, including Citigroup, UBS, Bank of America, and Barclays, have issued updated price targets and ratings.Sat 00:01
  • Bank of America and Citigroup adjusted target prices and raised price objectives for BDX stock.Sat 00:01

Related events

• MarketBeat provided consensus rating data for TuHURA Biosciences, Inc. on November 1, 2026.Nov 1
• MarketBeat provided stock average ratings while Leerink Partners upgraded and Barclays raised its price objective for Summit Therapeutics.Wed 17:14
• MarketBeat reports analyst recommendations for consumer staples companies BioHarvest Sciences Inc and Haleon.Tue 15:00
• MarketBeat provided analyst ratings for CPS Technologies Corp. on October 22, 2026.Oct 23
• MarketBeat provided consensus rating data for Zhengye Biotechnology Holding Limited on October 31, 2026.Oct 31